2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on Adjuvant Therapy in Stage III Melanoma: Is There a RFS Benefit to Adjuvant Pembrolizumab in Resected High-Risk Disease? What Is the Benefit of Dab + Tram in BRAF V600E / V600K Melanoma?

55 views
August 13, 2020
Comments 0
Login to view comments. Click here to Login